Our 60+ executive speaking faculty, armed with their industry experience, war stories and more, are here to help you demystify the legal IP landscape and strengthen your exclusivity strategies
DOWNLOAD THE EVENT AGENDA AND SEE WHAT SESSION EACH SPEAKER IS ON
If you wish to get involved, contact [email protected] for further information
Adrian Chew
PartnerBristowsAdrian Spillmann
Director of Intellectual PropertyValnevaAgathe Michel-De-Cazotte
PartnerCarpmaels & RansfordAgnieszka Deeg-Tyburska
General CounselPolpharmaAna Lopez Lozano
Lead Patent CounselZentivaAndre Andrade
VP PartnershipsRWSAndreas Robinson
Senior Counsel Intellectual Property & LitigationAmgenAnna Wolters-Hoehne
PartnerA & O ShearmanAnna is a highly experienced patent litigator advising primarily life sciences clients in global patent disputes. With about 20 years of practice in leading and coordinating high profile patent cases Anna develops both offensive and defensive patent strategies for her clients to protect their product portfolio nationally and in an international context.
Anna’s long-standing expertise covers patent infringement and preliminary injunction proceedings as well as patent damages proceedings before the German courts. She also advises on national compulsory licence cases and nullity actions as well as EPO opposition proceedings and the UPC. Anna regularly coordinates international patent disputes and advises clients in particular from the innovative pharmaceutical and medical device industries.
Axel Berger
PartnerBardehleBetsy Flanagan
PartnerCooleyBianca Vos
PartnerHoffmann EitleBoris Andrejas
Case HandlerDG CompBrian Coggio
CounselFish & RichardsonCecile Teles
Head of IPZentivaCecile is Head Patent Attorney at Zentiva. She has over a decade of experience in the pharmaceutical industry.
Cecile is uniquely experienced and knowledgeable in the pharma space as she has experience in-house at an elite innovator company (Sanofi), biologics (Merck Serono), and extensive generic experience she gained as Zentiva.
Cecile is an enthusiastic manager of her team and was a key member of the IP team in leading the transformation of Zentiva into an independent and competitive generic company after divestment from Sanofi.
Cecile is a qualified European Patent Attorney. She also holds a certificate from CEIPI in patent litigation and most recently completed her diploma as a Master of Laws in France.
Charlotte Weekes
PartnerPinsent MasonsChristina Brown-Marshall
PrincipalFish & RichardsonChristina Thomson
Managing AssociateSimmons & SimmonsChristof Bull
Associate General Patent CounselUCBChristoph Rehfuess
Head of IPSotioClaudia Milbradt
PartnerClifford ChanceCorinna Sundermann
Senior Vice President Intellectual PropertyFresenius KabiDenis Schertenleib
PartnerSchertenleib AvocatsDolores Cassidy
Head of Patent/SPC ExaminationIntellectual Property Office of IrelandDolores Cassidy, B.Sc. Ph.D., graduated from University College Dublin with a Ph.D. in Physical Chemistry. In 1998 she joined the Intellectual Property Office of Ireland as a Patent Examiner, with particular responsibility for the examination of Supplementary Protection Certificates (SPCs). In 2021 she was promoted to the position of Head of Patent/SPC Examination at the Irish Office.
Dorian Immler
Head of PatentsBayerEduardo Hallak
PartnerLicks AttorneyEduardo Hallak is one of the founding partners at Licks Attorneys and one of our leaders at the Sao Paulo office. For more than a decade, he has been working as a litigator before state and federal courts in Brazil in several complex disputes and leading cases involving Patent law, competition, and regulatory compliance, most of them pursuing the interests of clients in the area of life sciences. He also has extensive practice in trademark litigation as well as technology transfer contracts, working together with multinational clients to establish strong brand protection and licensing programs in the country. Mr. Hallak also currently teaches IP litigation in the Post-Graduation course at the prestigious Pontifical Catholic University of Rio de Janeiro (PUCRJ), has taught Civil Procedure at the at the Brazilian Association of IP Agents (ABAPI), and is often invited to lecture on procedural and strategic aspects of IP litigation, in addition to being a member of the Special Commission on Mediation of the Rio de Janeiro Chapter of the Brazilian Bar Association (OABRJ) and the Enforcement Committee of INTA.
Elodie Ferraty
Head of Chemistry DivisionINPIEva Ehlich
PartnerMaiwaldFilipe Pedro
Director of IPBIALFlorian Bechtel
Senior Counsel- Digital & Device IPSanofiFritz Gerritzen
PartnerA & O ShearmanGemma Barrett
PartnerA & O ShearmanGemma is an experienced and trusted advisor for some of the world’s leading life sciences and chemical companies. Her background in biochemistry means she specialises in complex technical disputes in the life sciences sector. She has more than fifteen years’ experience advising clients in patent litigation matters before the English Courts including securing preliminary injunctions. She is also experienced in advising on global cross-border litigation, and coordinating worldwide litigation, working closely with multi-disciplinary teams in the defence and enforcement of patent portfolios. She has developed innovative and successful strategies, often combining patent and regulatory law, to assist pharmaceutical companies in the enforcement of their rights.
Geoff Biegler
PartnerCooleyHa Kung Wong
Partner, Advisory Board MemberVenable, Centre for BiosimilarsHa Kung Wong has over 20 years of experience practicing general intellectual property law with an emphasis on complex patent and trade secret litigation as well as IP transactions and contract negotiations for mergers, acquisitions, and collaborations in pharmaceuticals, biologics, and chemistry. Cases Mr. Wong has litigated include those related to proton pump inhibitors, allergy eye drops, anti-epileptic drugs, anti-tussive, injectable microspheres, RNAi products, and other pharmaceuticals. Mr. Wong also has extensive experience with Inter Partes Review, Post Grant Review, intellectual property counseling, pharmaceutical regulatory counseling, pre-suit investigations, licensing, and due diligence.
Mr. Wong has his BS with high distinction in Chemistry and his BS in Biochemistry from the University of Illinois Urbana-Champaign and his JD, cum laude, from the University of Notre Dame. Mr. Wong is currently an elected member of the Venable Board, is an Advisory Board Member for the Center for Biosimilars, is Treasurer, Executive Committee member, and Board Trustee for the Foundation for Advancement of Diversity in IP Law (FADIPL) and serves as faculty for the National Institute of Trial Advocacy (NITA) and Lawline.
Hilary Pioro
Senior Patent CounselPolpharma BiologicsIsabelle Gundel
Senior Patent AttorneyHaleonIsobel Barry
PartnerCarpmaels & RansfordJames Horgan
Chief IP CounselMSDJiri Slavik
Director of IPAdalvoJudith Krens
PartnerPinsent MasonsJulia Pike
Global Head of IPSandozSince March 2020, Julia has been the Global Head of IP for Sandoz. In her previous roles with Sandoz, she has had a leading role in the first wave of US biosimilars litigation, including the first litigations on critical aspects of the governing legislation (the Biologics Price Competition and Innovation Act or BPCIA), culminating in the landmark US Supreme Court decision, Sandoz v Amgen.
Since leaving private practice at Corrs Chambers Westgarth, Julia has been in-house counsel for many years including at Mayne Pharma and Hospira Inc before joining Sandoz in 2008. While there, she has taken on roles in European public affairs and led Sandoz’s global IP litigation function as Global Head of IP Litigation. Through those roles, she has maintained a keen interest in IP strategy and litigation worldwide, including cases arising under the Hatch-Waxman and BPCIA legislation in the US, PM(NOC) regulations in Canada and litigation arising from patent linkage systems around the world.
Karin Pramberger
Intellectual Property DirectorPolpharma GroupKarin has been Intellectual Property Director at the Polpharma Group since April 2018. She is responsible for all patent and trade mark related activities. Prior to joining the Polpharma Group, Karin was Head of IP of Medichem, Spain, and worked in various positions within the patent department of Teva, Barr and Pliva. She spent 7 years in a law firm in Vienna, Austria, where she became European and Austrian patent and trade mark attorney. She studied Biotechnology in Vienna, Austria, and at the Ecole Nationale Supérieure de Chemie de Paris, France. In 2017 she graduated with an LLB from the University of London. Since 2005 she has been a tutor at CEIPI, University of Strasbourg, for the pre-exam and the C-part of the European Qualifying Exam.
Katherine Helm
PartnerDechertKatie Rooth
Lead IP Litigation CounselSandozKaushal Joshi
Senor Director Legal, IP and Product PortfolioKashiv BiosciencesKit Carter
Head of IP LitigationSandozKora Knuchel
Vice President, IP & LegalBrukerLaila Beynon
AD- Dispute ResolutionRegeneronLaila Beynon is Director, Dispute Resolution at Regeneron, responsible for the strategic co-ordination of ex-US patent litigation. She has a PhD in Biochemistry/Molecular Biology, 10 years’ private practice experience in life sciences patent litigation at Herbert Smith Freehills LLP, and prior to her role at Regeneron headed up the Patent Litigation team at BAT.
Lora Green
PartnerGemini LawPrior to joining Gemini, Lora was a senior partner at Wilson, Sonsini, Goodrich & Rosati, as part of the firm’s PTAB practice group.
Before entering private practice, Lora was a Lead Administrative Patent Judge at the U.S. Patent & Trademark Office, as well as a primary patent examiner in the pharmaceutical and biotechnology examining groups. While at the USPTO, she managed post-grant review proceedings, such as inter partes and post grant reviews.Manja Epping
PartnerTaylor WessingMarco Stief
PartnerMaiwaldMargaret O'Gara
Director of IPNanobiotixMargaret is a French and European patent attorney currently heading IP at a late development stage biotech in Paris, called Nanobiotix.
She started her professional career as a researcher in the pharma industry in the UK and France, before moving into patents in 2004.
Since then she has worked both in-house and in IP firms and spent nearly ten years with Santarelli before taking the IP position at Nanobiotix early 2020. Margaret has considerable experience in all aspects of European patent prosecution, and post grant proceedings, as well as strategies for filing new applications . She is interested in data exclusivity and prolonging the protection of innovative products.
Maria Lamottke
VP Business DevelopmentBiocollMarius-Benjamin Schneider
Head of LegalInsempraDr Martijn de Lange
Patent ExaminerNetherlands Patent OfficeMartin Schmidt
Life Science Technical JudgeUPCMax Haedicke
Honourable JudgeParis Central DivisionMichal Porubsky
Senior Litigation CounselNovo NordiskMortiz Ammelberg
PrincipalFish & RichardsonNicholas Mitrokostas
PartnerA & O ShearmanNick is the Managing Partner of the Boston office and an experienced Life Sciences trial attorney who focuses on representing innovator companies in intellectual property, trade secret, licensing and antitrust disputes. A litigator known for his trial skills, Nick has been lead counsel and gone to trial in dozens of ANDA and BPCIA litigations and has extensive experience representing clients in the pharmaceutical, biotechnology, and medical device industries in federal and state courts as well as before the Patent Trial and Appeal Board (PTAB). Nick also has expertise in counseling emerging and small and mid-cap Life Sciences companies in late stage drug development on issues pertaining to patent and regulatory exclusivities including patent term extension (PTE), patent listing requirements, and pre-commercial and launch assessments and litigation risks.
Dr Oliver Werner
Head Patent Department, Head SPC Working GroupGerman Patent and Trade Mark OfficePatrick Heckeler
PartnerBardehlePaul Calvo
DirectorSterne KesslerPedro Roman
IP CounselInsud PharmaPetra Bohanec Grabar
IP LeadSandozPetra Bohanec Grabar is a Slovenian and European Patent Attorney and holds a diploma of Patent Litigation in Europe from the University of Strasbourg.
Petra has extensive experience working in house. In her current role as Group Head in Sandoz, Petra leads a team of patent practitioners supporting development, in licensing and launch of generic products on global markets.
Petra holds a PhD in Biochemistry and Molecular Biology from the Faculty of Medicine, University of Ljubljana and is an author of twelve peer reviewed articles in the field of pharmacogenetics.
Roberto Romandini
Legal Member of the Board of AppealEPORoberto Romandini obtained his law degree from the University of Pisa and his LL.M. degree from the University of Munich, where he specialized in patent law. He completed his Ph.D. thesis on the patentability of human stem cells at the Max Planck Institute in Munich before practicing IP law at a leading IP law firm in Milan for 5 years. From 2013 he was a Senior Research Fellow at the Max Planck Institute for Innovation and Competition in Munich. Since 2019 he has been a legal member at the Boards of Appeal at the EPO.
Robin Ellis
PartnerReddie&GroseSabine Klepsch
Honourable JudgeUPC Local Division HamburgSara Burhart
Senior Counsel- Patent LitigationBATSherry Yao
PartnerKing & Wood MallesonsStefania Bergia
PartnerSimmonsStefanie Kies
Senior Director Intellectual PropertyPolpharma BiologicsStephen Reese
PartnerClifford ChanceSuzanne Renes
European Patent AttorneySanofiSuzanne graduated Cum Laude from Amsterdam University College in 2015 with a BSc in Biomedical Sciences. In 2016 she graduated from University College London with an MSc in Pharmaceutical Formulation and Entrepreneurship. She is a qualified Dutch and European Patent Attorney that started her career in the Pharma team at NLO in 2018. Since January 2022 she has been employed in the Ablynx team of Sanofi in Ghent, where she has been working as a patent attorney specializing in immunoglobulin single variable domains (camelid-derived VHH). In her free time, she enjoys learning new languages, playing badminton and dancing salsa.
Tamaris Bucher
Principal Patent AttorneyNovartisTamaris is a Principal Patent Attorney at Novartis. She has gained extensive experience in pharmaceuticals in her almost ten years at Novartis, as well as from a previous role at a patent law firm in Basel.
She specialises in patent matters relating to antibody technology and cell & gene therapies. She has expertise in patent prosecution and SPC issues, as well as a keen interest in following legal developments in these areas.
Tamaris is both a registered European Patent Attorney and Swiss Patent Attorney. Additionally, she has a background in Australian patent law, having completed a Master of Industrial Property at the University of Technology, Sydney.
Tobias Wuttke
PartnerBardehle Pagenberg